Karaki, H <br/><br/>
ETB receptor antagonist, IRL 1038, selectively inhibits the endothelin-induced endothelium-dependent vascular relaxation.  [electronic resource] 

 -  European journal of pharmacology  Feb 1993 
 - 371-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-2999 
<br/><br/><label>Standard No.: </label>10.1016/0014-2999(93)90112-u  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Drug Interactions<br/>Endothelin Receptor Antagonists<br/>Endothelins--pharmacology<br/>Endothelium, Vascular--drug effects<br/>Male<br/>Muscle Contraction--drug effects<br/>Muscle Relaxation--drug effects<br/>Muscle, Smooth, Vascular--drug effects<br/>Nitric Oxide--metabolism<br/>Peptide Fragments--pharmacology<br/>Rats<br/>Rats, Wistar